Moderna, Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $108.40M (year ended Dec 31, 2016) to $1.94B (year ended Dec 31, 2025), a compound annual growth rate of 37.8%. The fastest growth was +2200.2% in the year ended Dec 31, 2021; the weakest year was −64.4% (year ended Dec 31, 2023).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $1.94B | −39.9% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2026 |
| Dec 31, 2024 | $3.24B | −52.7% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2026 |
| Dec 31, 2023 | $6.85B | −64.4% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2026 |
| Dec 31, 2022 | $19.26B | +4.3% | Revenues | 10-K filed Feb 24, 2023 |
| Dec 31, 2021 | $18.47B | +2200.2% | Revenues | 10-K filed Feb 24, 2023 |
| Dec 31, 2020 | $803.00M | +1238.3% | Revenues | 10-K filed Feb 24, 2023 |
| Dec 31, 2019 | $60.00M | −55.6% | Revenues | 10-K filed Feb 25, 2022 |
| Dec 31, 2018 | $135.07M | −34.4% | Revenues | 10-K filed Feb 26, 2021 |
| Dec 31, 2017 | $205.82M | +89.9% | Revenues | 10-K filed Feb 27, 2020 |
| Dec 31, 2016 | $108.40M | — | Revenues | 10-K filed Mar 13, 2019 |
Moderna, Inc. reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Jun 30, 2026 | $145.00M | +2.1% | 10-Q filed Jul 31, 2026 |
| 3 months ended Mar 31, 2026 | $389.00M | +260.2% | 10-Q filed May 1, 2026 |
| 3 months ended Sep 30, 2025 | $1.02B | −45.4% | 10-Q filed Nov 6, 2025 |
| 3 months ended Jun 30, 2025 | $142.00M | −41.1% | 10-Q filed Jul 31, 2026 |
| 3 months ended Mar 31, 2025 | $108.00M | −35.3% | 10-Q filed May 1, 2026 |
| 3 months ended Sep 30, 2024 | $1.86B | +1.7% | 10-Q filed Nov 6, 2025 |
| 3 months ended Jun 30, 2024 | $241.00M | −29.9% | 10-Q filed Aug 1, 2025 |
| 3 months ended Mar 31, 2024 | $167.00M | −91.0% | 10-Q filed May 1, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 1682852 (raw data). Most recent filing in this dataset: 10-Q filed Jul 31, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.